ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05221	Acute myeloid leukemia	2/6	63/7206	0.00110324013928
ko05223	Non-small cell lung cancer	2/6	66/7206	0.00121035010085
ko05220	Chronic myeloid leukemia	2/6	85/7206	0.0020002489361
ko04917	Prolactin signaling pathway	2/6	87/7206	0.00209450022276
ko04012	ErbB signaling pathway	2/6	109/7206	0.00326855726397
ko05162	Measles	2/6	120/7206	0.00394869822506
ko04630	Jak-STAT signaling pathway	2/6	132/7206	0.00476022800765
ko04933	AGE-RAGE signaling pathway in diabetic complications	2/6	135/7206	0.00497433563975
ko05200	Pathways in cancer	3/6	492/7206	0.00541411680265
ko04152	AMPK signaling pathway	2/6	161/7206	0.0070149862099
ko04140	Autophagy - animal	2/6	164/7206	0.00727152672747
ko05161	Hepatitis B	2/6	173/7206	0.00806692044461
ko04062	Chemokine signaling pathway	2/6	201/7206	0.0107847332851
ko05203	Viral carcinogenesis	2/6	277/7206	0.0199336295778
ko05166	HTLV-I infection	2/6	292/7206	0.0220304097941
ko00512	Mucin type O-glycan biosynthesis	1/6	29/7206	0.0239131185429
ko04960	Aldosterone-regulated sodium reabsorption	1/6	41/7206	0.0336678118474
ko04973	Carbohydrate digestion and absorption	1/6	42/7206	0.0344770223328
ko05219	Bladder cancer	1/6	48/7206	0.0393204359922
ko04930	Type II diabetes mellitus	1/6	54/7206	0.0441435857678